Report Detail
Global Prostate Cancer Drugs Market Insights and Forecast to 2026
- RnM4149532 |
- 20 August, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
Prostate Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prostate Cancer Drugs market is segmented into
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application, the Prostate Cancer Drugs market is segmented into
Clinics
Hospitals
Other
Regional and Country-level Analysis
The Prostate Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prostate Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prostate Cancer Drugs Market Share Analysis
Prostate Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostate Cancer Drugs business, the date to enter into the Prostate Cancer Drugs market, Prostate Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
1 Study Coverage
- 1.1 Prostate Cancer Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Prostate Cancer Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Prostate Cancer Drugs Market Size Growth Rate by Type
- 1.4.2 Hormonal Therapy
- 1.4.3 Chemotherapy
- 1.4.4 Immunotherapy
- 1.4.5 Targeted Therapy
- 1.5 Market by Application
- 1.5.1 Global Prostate Cancer Drugs Market Size Growth Rate by Application
- 1.5.2 Clinics
- 1.5.3 Hospitals
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Prostate Cancer Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Prostate Cancer Drugs Revenue 2015-2026
- 2.1.2 Global Prostate Cancer Drugs Sales 2015-2026
- 2.2 Global Prostate Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Prostate Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Prostate Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prostate Cancer Drugs Competitor Landscape by Players
- 3.1 Prostate Cancer Drugs Sales by Manufacturers
- 3.1.1 Prostate Cancer Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Prostate Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Prostate Cancer Drugs Revenue by Manufacturers
- 3.2.1 Prostate Cancer Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Prostate Cancer Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Prostate Cancer Drugs Revenue in 2019
- 3.2.5 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Prostate Cancer Drugs Price by Manufacturers
- 3.4 Prostate Cancer Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Prostate Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prostate Cancer Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Prostate Cancer Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Prostate Cancer Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Prostate Cancer Drugs Sales by Type (2015-2020)
- 4.1.2 Global Prostate Cancer Drugs Revenue by Type (2015-2020)
- 4.1.3 Prostate Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Prostate Cancer Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Prostate Cancer Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Prostate Cancer Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Prostate Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Prostate Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Prostate Cancer Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Prostate Cancer Drugs Sales by Application (2015-2020)
- 5.1.2 Global Prostate Cancer Drugs Revenue by Application (2015-2020)
- 5.1.3 Prostate Cancer Drugs Price by Application (2015-2020)
- 5.2 Prostate Cancer Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Prostate Cancer Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Prostate Cancer Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Prostate Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Prostate Cancer Drugs by Country
- 6.1.1 North America Prostate Cancer Drugs Sales by Country
- 6.1.2 North America Prostate Cancer Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Prostate Cancer Drugs Market Facts & Figures by Type
- 6.3 North America Prostate Cancer Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Prostate Cancer Drugs by Country
- 7.1.1 Europe Prostate Cancer Drugs Sales by Country
- 7.1.2 Europe Prostate Cancer Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prostate Cancer Drugs Market Facts & Figures by Type
- 7.3 Europe Prostate Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Prostate Cancer Drugs by Region
- 8.1.1 Asia Pacific Prostate Cancer Drugs Sales by Region
- 8.1.2 Asia Pacific Prostate Cancer Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Prostate Cancer Drugs by Country
- 9.1.1 Latin America Prostate Cancer Drugs Sales by Country
- 9.1.2 Latin America Prostate Cancer Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Prostate Cancer Drugs Market Facts & Figures by Type
- 9.3 Central & South America Prostate Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Prostate Cancer Drugs by Country
- 10.1.1 Middle East and Africa Prostate Cancer Drugs Sales by Country
- 10.1.2 Middle East and Africa Prostate Cancer Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Corporation Information
- 11.1.2 AbbVie Description and Business Overview
- 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Prostate Cancer Drugs Products Offered
- 11.1.5 AbbVie Related Developments
- 11.2 Astellas Pharma
- 11.2.1 Astellas Pharma Corporation Information
- 11.2.2 Astellas Pharma Description and Business Overview
- 11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
- 11.2.5 Astellas Pharma Related Developments
- 11.3 Astra Zeneca
- 11.3.1 Astra Zeneca Corporation Information
- 11.3.2 Astra Zeneca Description and Business Overview
- 11.3.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
- 11.3.5 Astra Zeneca Related Developments
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Corporation Information
- 11.4.2 Johnson & Johnson Description and Business Overview
- 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
- 11.4.5 Johnson & Johnson Related Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description and Business Overview
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi Prostate Cancer Drugs Products Offered
- 11.5.5 Sanofi Related Developments
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Description and Business Overview
- 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
- 11.6.5 GlaxoSmithKline Related Developments
- 11.7 Merck Group
- 11.7.1 Merck Group Corporation Information
- 11.7.2 Merck Group Description and Business Overview
- 11.7.3 Merck Group Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Merck Group Prostate Cancer Drugs Products Offered
- 11.7.5 Merck Group Related Developments
- 11.8 Novartis
- 11.8.1 Novartis Corporation Information
- 11.8.2 Novartis Description and Business Overview
- 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Novartis Prostate Cancer Drugs Products Offered
- 11.8.5 Novartis Related Developments
- 11.9 Amgen
- 11.9.1 Amgen Corporation Information
- 11.9.2 Amgen Description and Business Overview
- 11.9.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Amgen Prostate Cancer Drugs Products Offered
- 11.9.5 Amgen Related Developments
- 11.10 Bayer HealthCare
- 11.10.1 Bayer HealthCare Corporation Information
- 11.10.2 Bayer HealthCare Description and Business Overview
- 11.10.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
- 11.10.5 Bayer HealthCare Related Developments
- 11.1 AbbVie
- 11.1.1 AbbVie Corporation Information
- 11.1.2 AbbVie Description and Business Overview
- 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Prostate Cancer Drugs Products Offered
- 11.1.5 AbbVie Related Developments
- 11.12 Janssen Pharmaceuticals
- 11.12.1 Janssen Pharmaceuticals Corporation Information
- 11.12.2 Janssen Pharmaceuticals Description and Business Overview
- 11.12.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Janssen Pharmaceuticals Products Offered
- 11.12.5 Janssen Pharmaceuticals Related Developments
- 11.13 Endo Pharmaceuticals
- 11.13.1 Endo Pharmaceuticals Corporation Information
- 11.13.2 Endo Pharmaceuticals Description and Business Overview
- 11.13.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Endo Pharmaceuticals Products Offered
- 11.13.5 Endo Pharmaceuticals Related Developments
- 11.14 BMS
- 11.14.1 BMS Corporation Information
- 11.14.2 BMS Description and Business Overview
- 11.14.3 BMS Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 BMS Products Offered
- 11.14.5 BMS Related Developments
- 11.15 Takeda Pharmaceuticals
- 11.15.1 Takeda Pharmaceuticals Corporation Information
- 11.15.2 Takeda Pharmaceuticals Description and Business Overview
- 11.15.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Takeda Pharmaceuticals Products Offered
- 11.15.5 Takeda Pharmaceuticals Related Developments
- 11.16 Northwest Biotherapeutics
- 11.16.1 Northwest Biotherapeutics Corporation Information
- 11.16.2 Northwest Biotherapeutics Description and Business Overview
- 11.16.3 Northwest Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Northwest Biotherapeutics Products Offered
- 11.16.5 Northwest Biotherapeutics Related Developments
- 11.17 Teva Pharmaceutical
- 11.17.1 Teva Pharmaceutical Corporation Information
- 11.17.2 Teva Pharmaceutical Description and Business Overview
- 11.17.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Teva Pharmaceutical Products Offered
- 11.17.5 Teva Pharmaceutical Related Developments
- 11.18 Boehringer Ingelheim
- 11.18.1 Boehringer Ingelheim Corporation Information
- 11.18.2 Boehringer Ingelheim Description and Business Overview
- 11.18.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Boehringer Ingelheim Products Offered
- 11.18.5 Boehringer Ingelheim Related Developments
- 11.19 Foresee Pharmaceuticals
- 11.19.1 Foresee Pharmaceuticals Corporation Information
- 11.19.2 Foresee Pharmaceuticals Description and Business Overview
- 11.19.3 Foresee Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Foresee Pharmaceuticals Products Offered
- 11.19.5 Foresee Pharmaceuticals Related Developments
- 11.20 Tokai Pharmaceuticals
- 11.20.1 Tokai Pharmaceuticals Corporation Information
- 11.20.2 Tokai Pharmaceuticals Description and Business Overview
- 11.20.3 Tokai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Tokai Pharmaceuticals Products Offered
- 11.20.5 Tokai Pharmaceuticals Related Developments
- 11.21 Spectrum Pharmaceuticals
- 11.21.1 Spectrum Pharmaceuticals Corporation Information
- 11.21.2 Spectrum Pharmaceuticals Description and Business Overview
- 11.21.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Spectrum Pharmaceuticals Products Offered
- 11.21.5 Spectrum Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Prostate Cancer Drugs Market Estimates and Projections by Region
- 12.1.1 Global Prostate Cancer Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Prostate Cancer Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Prostate Cancer Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Prostate Cancer Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Prostate Cancer Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Prostate Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Prostate Cancer Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Prostate Cancer Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Prostate Cancer Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Prostate Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Prostate Cancer Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Prostate Cancer Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Prostate Cancer Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Prostate Cancer Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Prostate Cancer Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Prostate Cancer Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Prostate Cancer Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Prostate Cancer Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Prostate Cancer Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Prostate Cancer Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Prostate Cancer Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Prostate Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Prostate Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prostate Cancer Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Prostate Cancer Drugs. Industry analysis & Market Report on Prostate Cancer Drugs is a syndicated market report, published as Global Prostate Cancer Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Prostate Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
